Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells

Stem Cells

Volumn 24, Issue 1, 2006, Pages 65-73

  Hermitte, Francis ^a   De La Grange, Philippe Brunet ^a   Belloc, Francis ^b   Praloran, Vincent ^a,b,d   Ivanovic, Zoran ^c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b University Hospital   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d CNRS Bordeaux Segalen University   (France)

Author keywords

CD34; Cell cycle; Hematopoietic stem cell; Hypoxia; Oxygen

Indexed keywords

CD34 ANTIGEN; INTERLEUKIN 3; TRANSFORMING GROWTH FACTOR BETA; OXYGEN; STEM CELL FACTOR;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL CYCLE G0 PHASE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COLONY FORMATION; FLOW CYTOMETRY; FUNCTIONAL STATUS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; OXYGEN CONCENTRATION; PLURIPOTENT STEM CELL; STEM CELL; TISSUE SPECIFICITY; UMBILICAL CORD BLOOD; ANIMAL; CELL CYCLE; CHEMISTRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD34; CELL CYCLE; CELL SURVIVAL; G0 PHASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; MICE; MICE, INBRED NOD; MICE, SCID; OXYGEN; STEM CELL FACTOR;

EID: 33644513357     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2004-0351     Document Type: Article

References (47)

1. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993;81:2844-2853.
2. Gunsilius E, Gastl G, Petzer AL. Hematopoietic stem cells. Biomed Pharmacother 2001;55:186-194.
3. Civin CI, Strauss LC, Brovall C et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984;133:157-165.
4. Ogawa M. Hematopoiesis. J Allergy Clin Immunol 1994;94:645-650.
5. Bonnet D. Haematopoietic stem cells. J Pathol 2002;197:430-440.
6. Ivanovic Z. Interleukin-3 and ex vivo maintenance of hematopoietic stem cells: facts and controversies. Eur Cytokine Netw 2004;15:6-13.
7. Porwol T, Ehleben W, Brand V et al. Tissue oxygen sensor function of NADPH oxidase isoforms, an unusual cytochrome aa3 and reactive oxygen species. Respir Physiol 2001;128:331-348.
8. Duling BR, Berne RM. Longitudinal gradients in periarteriolar oxygen tension. A possible mechanism for the participation of oxygen in local regulation of blood flow. Circ Res 1970;27:669-678.
9. Tondevold E, Eriksen J, Jansen E. Observations on long bone medullary pressures in relation to arterial PO2, PCO2 and pH in the anaesthetized dog. Acta Orthop Scand 1979;50:645-651.
10. Chow DC, Wenning LA, Miller WM et al. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models Biophys J 2001;81:685-696.
11. Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001;97:2293-2299.
12. Maeda H, Hotta T, Yamada H. Enhanced colony formation of human hemopoietic stem cells in reduced oxygen tension. Exp Hematol 1986; 14:930-934.
13. Broxmeyer HE, Cooper S, Gabig T. The effects of oxidizing species derived from molecular oxygen on the proliferation in vitro of human granulocyte-macrophage progenitor cells. Ann N Y Acad Sci 1989;554:177-184.
14. Broxmeyer HE, Cooper S, Lu L et al. Enhanced stimulation of human bone marrow macrophage colony formation in vitro by recombinant human macrophage colony-stimulating factor in agarose medium and at low oxygen tension. Blood 1990;76:323-329.
15. Koller MR, Bender JG, Miller WM et al. Reduced oxygen tension increases hematopoiesis in long-term culture of human stem and progenitor cells from cord blood and bone marrow. Exp Hematol 1992;20:264-270.
16. Koller MR, Bender JG, Papoutsakis ET et al. Effects of synergistic cytokine combinations, low oxygen, and irradiated stroma on the expansion of human cord blood progenitors. Blood 1992;80:403-411.
17. Mostafa SS, Miller WM, Papoutsakis ET. Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol 2000;111:879-889.
18. Mostafa SS, Papoutsakis ET, Miller WM. Oxygen tension modulates the expression of cytokine receptors, transcription factors, and lineage-specific markers in cultured human megakaryocytes. Exp Hematol 2001;29:873-883.
19. Laluppa JA, Papoutsakis ET, Miller WM. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages. Exp Hematol 1998;26:835-843.
20. Cipolleschi MG, D'Ippolito G, Bernabei PA et al. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro. Exp Hematol 1997;25:1187-1194.
21. Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 1993;82:2031-2037.
22. Ivanovic Z, Bartolozzi B, Bernabei PA et al. Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. Br J Haematol 2000;108:424-429.
23. Ivanovic Z, Belloc F, Faucher JL et al. Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells. Exp Hematol 2002;30:67-73.
24. Ivanovic Z, Dello Sbarba P, Trimoreau F et al. Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent. Transfusion 2000;40:1482-1488.
25. Danet GH, Pan Y, Luongo JL et al. Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest 2003;112:126-135.
26. 2 concentration (3%). STEM CELLS 2004;22:716-724.
27. Saxonhouse MA, Rimsza LM, Christensen RD et al. Effects of anoxia on megakaryocyte progenitors derived from cord blood CD34pos cells. Eur J Haematol 2003;71:359-365.
28. Scholzen T, Gerdes J, The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311-322.
29. Gothot A, Pyatt R, McMahel J et al. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0/G1 phase of the cell cycle. Blood 1997;90:4384-4393.
30. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 2000;96:4185-4193.
31. Cipolleschi MG, Rovida E, Ivanovic Z et al. The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. Leukemia 2000;14:735-739.
32. Ladd AC, Pyatt R, Gothot A et al. Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0. Blood 1997;90:658-668.
33. Traycoff CM, Halstead B, Rice S et al. Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells. Br J Haematol 1998;102:759-767
34. Ando K, Ajehenbaum-Cymbalista F, Griffin JD. Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells. Proc Natl Acad Sci U S A 1993;90:9571-9575.
35. Pierelli L, Marone M, Bonanno G et al. Transforming growth factor-beta1 causes transcriptional activation of CD34 and preserves haematopoietic stem/progenitor cell activity. Br J Haematol 2002;118:627-637.
36. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 2000;96:2022-2036.
37. Larsson J, Blank U, Helgadottir H et al. TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Blood 2003;102:3129-3135.
38. Collins PC, Nielsen LK, Patel SD et al. Characterization of hematopoietic cell expansion, oxygen uptake, and glycolysis in a controlled, stirred-tank bioreactor system. Biotechnol Prog 1998;14:466-472.
39. Noon WA, Willemze R, Falkenburg JH. Comparison of repopulating ability of hematopoietic progenitor cells isolated from human umbilical cord blood or bone marrow cells in NOD/SCID mice. Bone Marrow Transplant 1998;22(suppl 1):S58-S60.
40. Gothot A, van der Loo JC, Clapp DW et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998;92:2641-2649.
41. Summers YJ, Heyworth CM, de Wynter EA et al. Cord blood G(0) CD34+ cells have a thousand-fold higher capacity for generating progenitors in vitro than G(1) CD34+ cells. STEM CELLS 2001;19:505-513.
42. Wilpshaar J, Falkenburg JH, Tong X et al. Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice. Blood 2000;96:2100-2107.
43. Wilpshaar J, Bhatia M, Kanhai HH et al. Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cells. Blood 2002;100:120-127.
44. Bryder D, Jacobsen SE. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 2000;96:1748-1755.
45. Herrera C, Sanchez J, Torres A et al. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice. Br J Haematol 2001; 114:920-930.
46. Glimm H, Eaves CJ. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood 1999;94:2161-2168.
47. Jetmore A, Plett PA, Tong X et al. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood 2002;99:1585-1593.